BSP Press Release

Chemical Abstracts Service (CAS) indexes Clinical Anti-Inflammatory & Anti-Allergy Drugs, Current Microwave Chemistry and Current Organocatalysis

News release date: July 17, 2014

Bussum, Netherlands, 17 July 2014: Chemical Abstracts Service, a division of the American Chemical Society accepts to index three new journals Clinical Anti-Inflammatory & Anti-Allergy Drugs, and Current Microwave Chemistry and Current Organocatalysis published by Bentham Science Publishers.

Chemical Abstracts Service (CAS) aims to deliver comprehensive and useful digital information environment for scientific research and discovery.

Clinical Anti-Inflammatory & Anti-Allergy Drugs publishes original research, expert reviews, drug clinical trials and thematic issues in all core areas of translational and clinical anti-inflammatory & anti-allergy drug research. For details, please visit the journal website at: Clinical Anti-Inflammatory & Anti-Allergy Drugs.

Current Microwave Chemistry is an international peer-reviewed journal that publishes important contributions describing advances in the use of the microwave across the field of in chemistry, biology, medicine, biomedical science, and engineering. For details, please visit the journal website at:Current Microwave Chemistry.

Current Organocatalysis is an international peer-reviewed journal that publishes significant research in all areas of organocatalysis. For details, please visit the journal website at: Current Organocatalysis.

 

Bentham Science Publishers free 3 months trial is active in the following university:

 University:  DAYANAND MEDICAL COLLEGE & HOSPITAL 

About the university:

Dayanand Medical College & Hospital (DMCH) Ludhiana, Punjab, India is a 1326 bedded (Inclusive 800 teaching beds) tertiary care teaching hospital in North India. The institution has an imposing complex of modern buildings and is equipped with all kinds of modern facilities for providing excellent care to the patients and training to the undergraduate and postgraduate students. All the clinical departments, along with the diagnostic laboratories provide round-the-clock service at the campus.

 http://www.dmch.edu

Recent Issues of the Following Journals have been Published!

The Natural Products Journal, 4 Issue 1

7-22-2014 8-25-42 AM

Editor-in-Chief:

Francesco Epifano

Università “G. D’Annunzio”

Chieti-Pescara, Chieti Scalo (CH)
Italy

Aims & Scope

The Natural Products Journal a peer reviewed journal, aims to publish all the latest and outstanding developments in natural products.

The Natural Products Journal publishes original research articles, reviews, letters and guest edited issues on all aspects of research and development in the field including: isolation, purification, structure elucidation, synthesis and bioactivity of chemical compounds found in nature.

www.eurekaselect.com

 Abstracted & Indexed in:

Chemical Abstracts, J-Gate, PubsHub.

http://www.eurekaselect.com/123357/issue/1

For details, visit: http://benthamscience.com/journal/index.php?journalID=npj

Clinical Immunology, Endocrine & Metabolic Drugs, 1 Issue 1

7-22-2014 8-27-34 AM

Editor-in-Chief:

Emilio Jirillo

Professor of Immunology, University of Bari
Bari
Italy 

Aims & Scope

Clinical Immunology, Endocrine & Metabolic Drugspublishes original research, expert reviews, drug clinical trials and thematic issues in all core areas of translational and clinical immunology, endocrine & metabolic drug research.

The journal publishes pre-clinical and clinical studies on the development of new immunology, endocrine & metabolic agents. Clinical studies of new reported immunology, endocrine & metabolic drugs include Phase 1 – IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading to clinicians, toxicologists, medicinal chemists, and pharmacologists.

http://www.eurekaselect.com/123473/issue/1

For more details, visit: http://benthamscience.com/journal/index.php?journalID=ciemd

CNS & Neurological Disorders – Drug Targets , 13 Issue 5

Editor-in-Chief:

Stephen D. Skaper

Department of Pharmaceutical and Pharmacological Sciences
University of Padova
Padova
Italy

Aims & Scope

CNS & Neurological Disorders – Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes.

CNS & Neurological Disorders – Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of CNS & neurological drug targets. The journal also accepts for publication original research articles, letters, reviews and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

www.eurekaselect.com

Abstracted & Indexed in:

Science Citation Index Expanded, MEDLINE, PubMed, BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Chemical Abstracts, EMBASE/Excerpta Medica, PsycINFO, Current Contents®/Clinical Medicine, Journal Citation Reports/Science Edition, Scopus, Neuroscience Citation Index®, MediaFinder®-Standard Periodical Directory, Genamics JournalSeek, PubsHub, J-Gate.

http://www.eurekaselect.com/123446/issue/5

For more information, visit: http://benthamscience.com/journal/index.php?journalID=cnsnddt

Current Organic Chemistry, 18 Issue 10

7-22-2014 8-37-11 AM

Editor-in-Chief:

Atta-ur-Rahman

FRS
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK
Email: coc@benthamscience.org 

Aims & Scope

Current Organic Chemistry aims to provide in-depth reviews on the current progress in the fields of asymmetric synthesis, organo-metallic chemistry, bioorganic chemistry, heterocyclic chemistry, natural product chemistry and analytical methods in organic chemistry. The frontier reviews provide the current state of knowledge in these fields and are written by chosen experts who are internationally known for their eminent research contributions. The Journal also accepts high quality research papers, highlights and letters besides thematic issues in these fields. Current Organic Chemistry should prove to be of great interest to organic chemists in academia and industry who wish to keep abreast with recent developments in key fields of organic chemistry.

www.eurekaselect.com

Abstracted & Indexed in:

Science Citation Index, Science Citation Index Expanded, Journal Citation Reports/Science Edition, Current Contents®(Physical, Chemical and Earth Sciences), Chemistry Citation Index®, Chemical Abstracts, Science Citation Index Expanded, Scopus, PubsHub, Genamics JournalSeek,Research Alert, SciSearch, Engineering Village/Chimica, MediaFinder®-Standard Periodical Directory, J-Gate.

http://www.eurekaselect.com/123455/issue/10

For details, visit: http://benthamscience.com/journal/index.php?journalID=coc

SMI Event!!

Clinical Trials in CNS

P-123-200x200

11-12 November 2014

 SMi is proud to announce its 13th annual Clinical Trials in CNS Conference. With an ever increasing average life expectancy, neurodegenerative diseases are becoming more prevalent in society. With this comes the need for new and improved therapies for treating neurodegenerative conditions. From Alzheimer’s to Parkinson’s disease, the target and mechanism by which a disease manifests itself presents unique challenges in how to approach such treatments not to mention ethical and legal issues behind treatment and trial design.

This conference will give delegates the opportunity to gain additional insights into the best practices in clinical trials, as well as address the challenges in CNS research and by looking at the latest pre-clinical and clinical studies.

This is an opportunity not to be missed, as we delve into the complex and exciting world of Central Nervous System discovery, allowing delegates to learn, explore and debate the key areas of CNS, its preclinical discovery and its clinical trials.

 For details, visit: http://www.smi-online.co.uk/2014clinicaltrialscns7.asp